Indefinite Delivery Contract SPE2DU25D7071

The federal contract IDV award is an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and was awarded on November 13, 2025.

The purpose of this IDC is to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The contract will cover a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The contract will be awarded on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.